Noxiptylin and masked depression

E. Sacchetti, E. Smeraldi, L. Bellodi, S. Bottinelli, C. Altamura

Research output: Contribution to journalArticlepeer-review


An open trial was undertaken to verify the effectiveness of low doses of Noxiptylin (30 mg per day for 30 days) in treatment of episodes of masked depression in a homogeneous cluster of patients (22 subjects) previously diagnosed as primary depressed. Coefficients of regression for intensity of the selected HAMILTON scores over the period of treatment indicate a decrease of the symptoms with time. The analysis shows that the greatest effect of the treatment on the symptoms appeared during the first 8 days.

Original languageEnglish
Pages (from-to)59-63
Number of pages5
Issue number1
Publication statusPublished - 1978

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine


Dive into the research topics of 'Noxiptylin and masked depression'. Together they form a unique fingerprint.

Cite this